Differential	differential	O	O	O	O
diagnosis	diagnosis	O	O	O	O
of	of	O	O	O	O
high	high	O	O	O	O
serum	serum	O	O	O	O
creatine	creatine	CHEMICALS	O	OTHERS	I
kinase	kinase	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
in	in	O	O	O	O
systemic	systemic	O	O	OTHERS	I
lupus	lupus	O	O	OTHERS	I
erythematosus	erythematosus	O	O	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
the	the	O	O	O	O
clinical	clinical	O	O	O	O
and	and	O	O	O	O
bioptic	bioptic	O	O	O	O
findings	findings	O	O	O	O
for	for	O	O	O	O
a	a	O	O	O	O
57-year-old	57-year-old	O	O	O	O
woman	woman	O	O	O	O
with	with	O	O	O	O
severe	severe	O	O	O	O
chloroquine-induced	chloroquine-induced	O	O	O	O
myopathy	myopathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Since	since	O	O	O	O
1989	1989	O	O	O	O
,	,	O	O	O	O
she	she	O	O	O	O
had	had	O	O	O	O
been	been	O	O	O	O
suffering	suffering	O	O	O	O
from	from	O	O	O	O
systemic	systemic	O	O	OTHERS	I
lupus	lupus	O	O	OTHERS	I
erythematosus	erythematosus	O	O	OTHERS	I
(	(	O	O	O	O
SLE	sle	O	O	OTHERS	I
)	)	O	O	O	O
with	with	O	O	O	O
renal	renal	O	O	OTHERS	I
involvement	involvement	O	O	OTHERS	I
and	and	O	O	O	O
undergone	undergone	O	O	O	O
periods	periods	O	O	O	O
of	of	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
azathioprine	azathioprine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
cyclophosphamide	cyclophosphamide	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Additional	additional	O	O	O	O
therapy	therapy	O	O	O	O
with	with	O	O	O	O
chloroquine	chloroquine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
CQ	cq	O	O	OTHERS	I
)	)	O	O	O	O
was	was	O	O	O	O
started	started	O	O	O	O
because	because	O	O	O	O
of	of	O	O	O	O
arthralgia	arthralgia	O	O	OTHERS	I
.	.	O	O	O	O

At	at	O	O	O	O
the	the	O	O	O	O
same	same	O	O	O	O
time	time	O	O	O	O
,	,	O	O	O	O
slightly	slightly	O	O	O	O
increased	increased	O	O	O	O
creatine	creatine	CHEMICALS	O	OTHERS	I
kinase	kinase	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
CK	ck	O	O	O	O
)	)	O	O	O	O
levels	levels	O	O	O	O
were	were	O	O	O	O
noted	noted	O	O	O	O
.	.	O	O	O	O

Myositis	myositis	O	O	OTHERS	I
was	was	O	O	O	O
suspected	suspected	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
steroids	steroids	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
CK	ck	O	O	O	O
increase	increase	O	O	O	O
persisted	persisted	O	O	O	O
,	,	O	O	O	O
however	however	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
she	she	O	O	O	O
developed	developed	O	O	O	O
progressive	progressive	O	O	O	O
muscular	muscular	O	DISEASE	OTHERS	I
weakness	weakness	O	DISEASE	OTHERS	I
and	and	O	O	O	O
muscular	muscular	O	DISEASE	OTHERS	I
atrophy	atrophy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Routine	routine	O	O	O	O
controls	controls	O	O	O	O
revealed	revealed	O	O	O	O
markedly	markedly	O	O	O	O
elevated	elevated	O	O	O	O
CK	ck	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
1,700	1,700	O	O	O	O
U/l	u/l	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
neurological	neurological	O	O	O	O
and	and	O	O	O	O
electrophysiological	electrophysiological	O	O	O	O
findings	findings	O	O	O	O
were	were	O	O	O	O
not	not	O	O	O	O
typical	typical	O	O	O	O
of	of	O	O	O	O
myositis	myositis	O	O	OTHERS	I
.	.	O	O	O	O

Thus	thus	O	O	O	O
,	,	O	O	O	O
muscle	muscle	O	O	O	O
biopsy	biopsy	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
deltoid	deltoid	O	O	O	O
muscle	muscle	O	O	O	O
was	was	O	O	O	O
performed	performed	O	O	O	O
in	in	O	O	O	O
order	order	O	O	O	O
to	to	O	O	O	O
exclude	exclude	O	O	O	O
polymyositis	polymyositis	O	O	OTHERS	I
or	or	O	O	O	O
toxic	toxic	O	O	O	O
myopathy	myopathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

As	as	O	O	O	O
it	it	O	O	O	O
revealed	revealed	O	O	O	O
chloroquine-induced	chloroquine-induced	O	O	O	O
myopathy	myopathy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
medication	medication	O	O	O	O
was	was	O	O	O	O
stopped	stopped	O	O	O	O
.	.	O	O	O	O

Discriminating	discriminating	O	O	O	O
between	between	O	O	O	O
primary	primary	O	O	O	O
SLE-induced	sle-induced	O	O	O	O
affection	affection	O	O	OTHERS	I
of	of	O	O	OTHERS	I
the	the	O	O	OTHERS	I
musculoskeletal	musculoskeletal	O	O	OTHERS	I
system	system	O	O	OTHERS	I
and	and	O	O	O	O
drug-induced	drug-induced	O	O	O	O
side	side	O	O	O	O
effects	effects	O	O	O	O
is	is	O	O	O	O
important	important	O	O	O	O
for	for	O	O	O	O
appropriate	appropriate	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
SLE	sle	O	O	OTHERS	I
patients	patients	O	O	O	O
.	.	O	O	O	O

